Allogene Therapeutics Announces Q2 Investor Conference Participation

SOUTH SAN FRANCISCO, Calif., April 09, 2024 -- Allogene Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T products for cancer and...

Related Keywords

Christine Cassiano ,Nasdaq ,Allogene Therapeutics Inc ,Corporate Affairs Brand Strategy ,Twitter ,Securities Life Sciences Conference ,Goldman Sachs ,Linkedin ,Genuity Horizons ,Oncology Virtual ,Life Sciences Conference ,Markets Global Healthcare Conference ,Annual Healthcare Conference ,South San Francisco ,Forward Looking Statements ,Private Securities Litigation Reform Act ,Annual Report ,Allogene Therapeutics ,Investor Contact ,Chief Corporate Affairs ,Brand Strategy ,Markets ,